Compugen (CGEN) Equity Average (2010 - 2015)
Compugen's (CGEN) quarterly Equity Average came in at $98.2 million in Q2 2015, down 0.86% year-on-year from $99.0 million in Q2 2014, and down 5.17% quarter-over-quarter from $103.5 million in Q1 2015.
Compugen (CGEN) Equity Average (2010 - 2015) Analysis & Trends
Compugen has disclosed Equity Average across 6 years of filings, most recently posting $98.2 million for Q2 2015.
- Equity Average for Q2 2015 came in at $98.2 million, down 0.86% year-over-year; the trailing twelve-month figure through Jun 2015 was $98.2 million (down 0.86% YoY), and the FY2025 annual result was $78.8 million, up 30.86% from the prior year.
- Equity Average came in at $98.2 million for Q2 2015 at Compugen, down from $103.5 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $106.2 million in Q4 2014 to a low of $18.2 million in Q4 2012.
- The 5-year median for Equity Average is $25.2 million (2011), against an average of $47.2 million.
- Across the five-year window, Equity Average fell 26.03% in 2012 and jumped 366.41% in 2014, its largest moves.
- Compugen's Equity Average stood at $20.9 million in 2011, then declined by 12.97% to $18.2 million in 2012, then jumped by 62.03% to $29.5 million in 2013, then jumped by 260.55% to $106.2 million in 2014, then decreased by 7.56% to $98.2 million in 2015.
- The last three Equity Average figures came in at $98.2 million (Q2 2015), $103.5 million (Q1 2015), and $106.2 million (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 516.41 Mn |
| 10 | Compugen | 191.48 Mn | 99.73 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 98.18 Mn |
| Mar 31, 2015 | 103.54 Mn |
| Dec 31, 2014 | 106.22 Mn |
| Sep 30, 2014 | 102.22 Mn |
| Jun 30, 2014 | 99.04 Mn |
| Mar 31, 2014 | 65.92 Mn |
| Dec 31, 2013 | 29.46 Mn |
| Sep 30, 2013 | 23.87 Mn |
| Jun 30, 2013 | 21.23 Mn |
| Mar 31, 2013 | 19.71 Mn |
| Dec 31, 2012 | 18.18 Mn |
| Sep 30, 2012 | 20.29 Mn |
| Jun 30, 2012 | 21.57 Mn |
| Mar 31, 2012 | 20.42 Mn |
| Dec 31, 2011 | 20.89 Mn |
| Sep 30, 2011 | 24.01 Mn |
| Jun 30, 2011 | 26.37 Mn |
| Mar 31, 2011 | 27.60 Mn |
| Dec 31, 2010 | 27.57 Mn |
| Sep 30, 2010 | 26.60 Mn |